Functionalized quinoxaline derivatives are well known in pharmaceutical industry. They have been shown to possess antibacterial activity (Kim et al. 2004) and as PDGF-R tyrosine kinase inhibitor (He et al. 2003).
In the crystal structure of the title compound, C 22 H 19 FN 4 , the quinoxaline system makes dihedral angles of 32.07 (13) and 69.64 (13) with the 4-fluorophenyl and pyridine rings, respectively. The 4-fluorophenyl ring makes a dihedral angle of 71.77 (16) with the pyridine ring. The crystal structure is stabilized by intermolecular N-HÁ Á ÁN hydrogen bonding.
Related literature
For chinoxaline derivatives and their biological activity, see: He et al. (2003) ; Kim et al. (2004) . Table 1 Hydrogen-bond geometry (Å , ).
Experimental
Symmetry code: (i) Àx þ 1; Ày þ 1; Àz þ 1.
Data collection: APEX2 (Bruker, 2006); cell refinement: SAINT (Bruker, 2006); data reduction: SAINT; program(s) used to solve structure: SIR97 (Altomare et al., 1999); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: PLATON (Spek, 2009); software used to prepare material for publication: PLATON. 
